Ending Eclampsia, March 2019 This study demonstrates how ministries of Health might use these missed opportunities to detect pre-eclampsia (and potentially other conditions) and prevent deterioration by providing anti-hypertensives and magnesium sulphate to stabilize and refer women. Download the report…
Tag Archive for magnesium sulphate
Assessing the effect of a primary health care intervention for improving pre-eclampsia and eclampsia knowledge and practice in Bangladesh
Ending Eclampsia, 2019 This intervention, which targeted PHC facilities, has resulted in a number of notable successes. Results showed improved PHC provider knowledge, abilities, and practices for detecting, preventing, and managing PE/E, improved facility readiness to provide PE/E services, improved…
Prophylactic magnesium sulphate in prevention of eclampsia in women with severe preeclampsia: randomised controlled trial (PIPES trial)
Journal of Obstetrics and Gynaecology, 2018 This study shows that a short regime of magnesium sulphate using only the loading dose in the prevention of seizures from pre-eclampsia is an effective alternative to the low-dose Dhaka regime. These findings call…
Primary Health Care-Preeclampsia/Eclampsia Plus Model
Ending Eclampsia, 2018 Starting in 2016, Ending Eclampsia initiated six additional implementation research studies in three countries – Bangladesh, Nigeria, Pakistan – to identify and assess additional components that, in conjunction with the Core Model, can further improve prevention, detection,…
What ails good policies on prevention and management of pre-eclampsia and eclampsia: Two counties in Kenya
By Charity Ndwiga, Program Officer In Kenya, despite the maternal mortality rate remaining high—between 2003 and 2014 (more than 400 deaths per 100,000 live births)—the proportion of mothers accessing antenatal care (ANC) and emergency obstetric and newborn care (EmONC) increased…
Maternal outcomes after 12 hours and 24 hours of magnesium sulfate therapy for eclampsia
International Journal of Obstetrics and Gynecology, 2016 Results from this study showed that among the 132 patients in the study group and 72 patients in the control group, no convulsions recurred in either group after the completion of treatment. Twelve…
The effect of loading dose of magnesium sulfate on uterine, umbilical, and fetal middle cerebral arteries Doppler in women with severe preeclampsia: A case control study
Hypertension in Pregnancy, 2016 Intravenous administration of magnesium sulfate in pregnant women with severe pre-eclampsia resulted in a decrease in umbilical artery, uterine artery, and fetal middle cerebral artery Doppler indices and reduced resistance to blood flow.
A comparison between the two methods of magnesium sulfate administration for duration of 12 versus 24 h after delivery in patients with severe preeclampsia
The Journal of Maternal-Fetal & Neonatal Medicine, 2015 The women of the two groups did not have significant difference according to age, BMI, parity and gravidity, gestational age at the time of delivery. Results showed that administration of magnesium sulphate…
Gaps and opportunities for pre-eclampsia and eclampsia care in Ethiopia
Ending Eclampsia, 2018 This brief provides recommendations for closing gaps in PE/E detection, treatment, and management in Ethiopia at national, health systems, and community levels.
Risk factors for pre-eclampsia and eclampsia in Cambodia
Ending Eclampsia, 2017 Cambodia-specific data on demographics, health risks, barriers to accessing care, pregnancy-related care, maternal death data, newborn/infant death data, national/provincial policies, and delivery capacity.
